CN101342173A - 洛贝林在制备治疗神经元凋亡疾病的药物中的应用 - Google Patents
洛贝林在制备治疗神经元凋亡疾病的药物中的应用 Download PDFInfo
- Publication number
- CN101342173A CN101342173A CNA2007100437583A CN200710043758A CN101342173A CN 101342173 A CN101342173 A CN 101342173A CN A2007100437583 A CNA2007100437583 A CN A2007100437583A CN 200710043758 A CN200710043758 A CN 200710043758A CN 101342173 A CN101342173 A CN 101342173A
- Authority
- CN
- China
- Prior art keywords
- lobeline
- acid
- application according
- disease
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (22)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007100437583A CN101342173A (zh) | 2007-07-13 | 2007-07-13 | 洛贝林在制备治疗神经元凋亡疾病的药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007100437583A CN101342173A (zh) | 2007-07-13 | 2007-07-13 | 洛贝林在制备治疗神经元凋亡疾病的药物中的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101342173A true CN101342173A (zh) | 2009-01-14 |
Family
ID=40244365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007100437583A Pending CN101342173A (zh) | 2007-07-13 | 2007-07-13 | 洛贝林在制备治疗神经元凋亡疾病的药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101342173A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103371966A (zh) * | 2012-04-17 | 2013-10-30 | 上海禾丰制药有限公司 | 盐酸洛贝林注射液及其制剂工艺 |
CN107007547A (zh) * | 2017-05-26 | 2017-08-04 | 北京市永康药业有限公司 | 盐酸洛贝林注射液的制备方法 |
WO2020206511A1 (en) * | 2019-04-12 | 2020-10-15 | Sopharma Ad | Oral pharmaceutical composition with a plant alkaloid for treatment of dependencies |
-
2007
- 2007-07-13 CN CNA2007100437583A patent/CN101342173A/zh active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103371966A (zh) * | 2012-04-17 | 2013-10-30 | 上海禾丰制药有限公司 | 盐酸洛贝林注射液及其制剂工艺 |
CN107007547A (zh) * | 2017-05-26 | 2017-08-04 | 北京市永康药业有限公司 | 盐酸洛贝林注射液的制备方法 |
WO2020206511A1 (en) * | 2019-04-12 | 2020-10-15 | Sopharma Ad | Oral pharmaceutical composition with a plant alkaloid for treatment of dependencies |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
van Amerongen et al. | Effects on spasticity and neuropathic pain of an oral formulation of Δ9-tetrahydrocannabinol in patients with progressive multiple sclerosis | |
JP2021191797A (ja) | 癲癇の治療におけるカンナビノイドの使用 | |
US5151419A (en) | Composition for the treatment of schizophrenia | |
Xie et al. | Progress in target drug molecules for Alzheimer's disease | |
CN104853755B (zh) | 包含沃替西汀和多奈哌齐的组合物 | |
CN108135872A (zh) | 用于治疗认知缺陷的谷氨酰胺拮抗剂 | |
WO2008000142A1 (fr) | Agoniste du transporteur de la dopamine et ses utilisations | |
US20210154156A1 (en) | Application of compound in inhibiting ab accumulation and treating alzheimer's disease | |
AU2019310013A1 (en) | Use of riluzole prodrugs to treat alzheimer's disease | |
KR20190137936A (ko) | 뇌 위축 예방 또는 치료제 | |
CN101342173A (zh) | 洛贝林在制备治疗神经元凋亡疾病的药物中的应用 | |
CN107205986A (zh) | 异丁司特和利鲁唑的组合及其使用方法 | |
CN109562097B (zh) | 穿心莲内酯治疗多发性硬化的进行形式 | |
Zhao et al. | Dihydroartemisinin ameliorates decreased neuroplasticity-associated proteins and excessive neuronal apoptosis in APP/PS1 mice | |
Maurya et al. | Current medication trends and global impact on neurodegenerative disorders | |
RU2671566C2 (ru) | Фармацевтическая композиция для профилактики и лечения сенильной деменции и способ её получения | |
CN101224201B (zh) | 多巴胺转运蛋白和去甲肾上腺素转运蛋白双重抑制剂的应用 | |
Ma et al. | Shi‐Zhen‐An‐Shen Decoction, a Herbal Medicine That Reverses Cuprizone‐Induced Demyelination and Behavioral Deficits in Mice Independent of the Neuregulin‐1 Pathway | |
EP3838272A2 (en) | Composition for prevention or treatment of neurodegenerative disease | |
CN100431539C (zh) | 乙酰胆碱酯酶抑制剂在制备治疗帕金森病药物中的应用 | |
CN109700853A (zh) | 一种组合物及其在制备防治癫痫的药物中的应用 | |
Chayng et al. | Anti-diabetic activity of diphenhydramine in diabetic rats | |
Misra et al. | A study of motor activity and catecholamine levels in different brain regions following Japanese encephalitis virus infection in rats | |
CN111032048B (zh) | 丁螺环酮用于治疗功能性头晕的用途 | |
US20240148708A1 (en) | Method of treating amyotrophic lateral sclerosis with pridopidine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SINO-AMERICAN GUOLIAN (SHANGHAI) BIOTECHNOLOGY RES Free format text: FORMER OWNER: HEHONG BIO-TECH (SHANGHAI) CO., LTD. Effective date: 20120220 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201203 PUDONG NEW AREA, SHANGHAI TO: 200333 PUTUO, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120220 Address after: 200333, room 2, building 879, Lane 307, Zhongjiang Road, Shanghai, Putuo District Applicant after: Guolian (Shanghai) Biotechnology Research Co., Ltd. Address before: 201203 Shanghai Guo Shou Jing Road, Zhangjiang High Tech Park of Pudong New Area No. 351 Building No. 2 room 694-11 Applicant before: Hehong Biotechnology (Shanghai) Co., Ltd. |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20090114 |